Buspirone in the Treatment of 2-6 Year Old Children With Autistic Disorder

NCT00873509 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

166

Enrollment

INDIV

Sponsor class

Conditions

Autistic Disorder

Interventions

DRUG: Buspirone
DRUG: Buspirone
DRUG: Placebo

Sponsor

Chugani, Diane C.

Collaborators

[object Object]